Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study - Summary - MDSpire

Risk factors for disease generalization in acetylcholine receptor antibody-positive ocular myasthenia: a multicenter retrospective study

  • By

  • Lorenzo Verriello

  • Roberto Sartor

  • Fabrizio Bellizzi

  • Chiara Dalla Torre

  • Maria Elena Pessa

  • Marco Belluzzo

  • Alessio Bratina

  • Magda Quagliotto

  • Chiara Rosa Mancinelli

  • Michele Rana

  • Fulvio Pasquin

  • Martina Fabris

  • Giada Pauletto

  • Miriam Isola

  • Maria De Martino

  • Paolo Manganotti

  • Mariarosaria Valente

  • May 25, 2026

  • 0 min

Share

Objective:

To identify factors associated with secondary generalization in patients with ocular-onset myasthenia gravis (OoMG) who were positive for anti–acetylcholine receptor (AChR) antibodies.

Key Findings:
  • 47.1% of patients developed generalized myasthenia gravis (gMG) during follow-up.
  • Higher anti-AChR antibody titers (HR 3.37, p = 0.002) and abnormal repetitive nerve stimulation of facial muscles (HR 2.49, p = 0.020) were associated with secondary generalization.
  • No independent predictors were identified in multivariable analysis.
Interpretation:

Higher anti-AChR antibody titers and abnormal facial repetitive nerve stimulation may indicate increased risk of secondary generalization in seropositive OoMG, although they did not independently predict generalization in multivariable analysis.

Limitations:
  • The study is retrospective and may be subject to selection bias.
  • The sample size may limit the generalizability of the findings.
Conclusion:

The combined assessment of identified factors may support early clinical risk stratification; larger prospective studies are needed to validate these findings.

Original Source(s)

Related Content